Evidence map›Paper›PMID 30349250›Full record

ReviewInternational journal of nanomedicine2018

Drug delivery systems for elemene, its main active ingredient β-elemene, and its derivatives in cancer therapy.

Bingtao Zhai, Yiying Zeng, Zhaowu Zeng, Nana Zhang, Chenxi Li, Yijun Zeng, Yu You, Shuling Wang, Xiabin Chen, Xinbing Sui and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in International journal of nanomedicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 3 pooled it
3.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 3 syntheses or guidelines pooled it, 147 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Exosome-like nanoparticles derived fromInternational journal of pharmaceutics: X · 2026
    Article
  5. Advances in Aptamer Drug Delivery Systems for Treatment of Glioblastoma.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Exploration and mutagenesis of the germacrene A synthase fromSynthetic and systems biotechnology · 2025
    Article
  17. Article
  18. Review
  19. Article
  20. Review

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Bingtao ZhaiCollege of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Yiying ZengHolistic Integrative Pharmacy Institutes, Hangzhou Normal University, Hangzhou, Zhejiang, China, xbs@dljg.sina.net; artgreenking@126.com.
Zhaowu ZengHolistic Integrative Pharmacy Institutes, Hangzhou Normal University, Hangzhou, Zhejiang, China, xbs@dljg.sina.net; artgreenking@126.com.
Nana ZhangHolistic Integrative Pharmacy Institutes, Hangzhou Normal University, Hangzhou, Zhejiang, China, xbs@dljg.sina.net; artgreenking@126.com.
Chenxi LiHolistic Integrative Pharmacy Institutes, Hangzhou Normal University, Hangzhou, Zhejiang, China, xbs@dljg.sina.net; artgreenking@126.com.
Yijun ZengHolistic Integrative Pharmacy Institutes, Hangzhou Normal University, Hangzhou, Zhejiang, China, xbs@dljg.sina.net; artgreenking@126.com.
Yu YouCollege of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Shuling WangHolistic Integrative Pharmacy Institutes, Hangzhou Normal University, Hangzhou, Zhejiang, China, xbs@dljg.sina.net; artgreenking@126.com.
Xiabin ChenHolistic Integrative Pharmacy Institutes, Hangzhou Normal University, Hangzhou, Zhejiang, China, xbs@dljg.sina.net; artgreenking@126.com.
Xinbing SuiHolistic Integrative Pharmacy Institutes, Hangzhou Normal University, Hangzhou, Zhejiang, China, xbs@dljg.sina.net; artgreenking@126.com.
Tian XieHolistic Integrative Pharmacy Institutes, Hangzhou Normal University, Hangzhou, Zhejiang, China, xbs@dljg.sina.net; artgreenking@126.com.
Hangzhou Normal University · CNChengdu University of Traditional Chinese Medicine · CNShanghai University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

β-elemene is a noncytotoxic Class II antitumor drug extracted from the traditional Chinese medicine

Indexed as

Drug Delivery SystemsAnimalsHumansLiposomesNanoparticlesNeoplasmsSesquiterpenesbeta-elemeneelemeneLiposomesSesquiterpenesderivativedrug delivery systempharmacokineticssafetyβ-elemene

Identifiers

PMID30349250
PMCPMC6186893
OpenAlexW2896184246

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.